Feb 26, 2026 03:24PM
Dec 21, 2025 04:00AM
Nov 13, 2025 04:33PM
Nov 4, 2025 09:05AM
Oct 31, 2025 06:12AM
Oct 27, 2025 06:53AM
Oct 27, 2025 12:29AM Fate Therapeutics presents lupus trial data showing patient responses
Sep 3, 2025 06:20AM
Aug 13, 2025 05:24AM
Aug 12, 2025 05:31PM
Jul 2, 2025 06:39AM
Jun 12, 2025 07:25AM
Jun 11, 2025 01:00PM
Jun 11, 2025 09:02AM Fate Therapeutics (FATE) Announces Updated Clinical Data for FT819 Off-the-shelf CAR T-cell Product Candidate Demonstrating Durability of Drug-free Remission for Severe Lupus Nephritis
May 30, 2025 04:30PM
May 28, 2025 05:55PM
May 14, 2025 04:30AM
May 13, 2025 06:12PM
Apr 14, 2025 08:01AM
Mar 6, 2025 09:54AM
Mar 6, 2025 05:19AM Fate Therapeutics (FATE) PT Lowered to $8 at Jefferies
Mar 5, 2025 04:53PM
Jan 2, 2025 04:00PM
Dec 9, 2024 04:02PM
Nov 29, 2024 01:05PM
Nov 18, 2024 03:49PM
Nov 18, 2024 02:11PM
Nov 18, 2024 01:31PM Stifel Reiterates Hold Rating on Fate Therapeutics (FATE)
Nov 18, 2024 11:22AM
Nov 18, 2024 08:05AM
Nov 13, 2024 08:53AM
Nov 12, 2024 09:22PM
Aug 14, 2024 02:05PM
Aug 14, 2024 10:08AM
Aug 14, 2024 08:37AM Fate Therapeutics (FATE) PT Lowered to $5 at Stifel
Aug 14, 2024 08:23AM
Aug 13, 2024 05:07PM
Aug 13, 2024 05:07PM
Jul 31, 2024 08:03AM
Jun 17, 2024 03:50AM
Feb 9, 2022 02:37PM
Sep 10, 2021 02:48PM Form SC 13G FATE THERAPEUTICS INC Filed by: ARK Investment Management LLC
Feb 24, 2021 06:44AM
Feb 23, 2021 06:51AM
Feb 17, 2021 09:29AM

353,174 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All